Class IITerminated

Rifampin Capsules USP recall

FDA recall D-0437-2024 · initiated Mar 21, 2024

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Subpotent Drug

Details

Product: Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06
Recalling company: Lupin Pharms
Classification: Class II
Status: Terminated
Type: Voluntary: Firm initiated
Distribution: Nationwide within the United States
Initiated: Mar 21, 2024
FDA report date: Apr 17, 2024

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0437-2024 ↗

← All drug recalls